Pricing Log in Create free account

PMGC Holdings Inc. (ELAB) vs Kairos Pharma, Ltd. (KAPA)

PMGC Holdings Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. PMGC Holdings Inc. and Kairos Pharma, Ltd. are of similar size ($2.5M and $2.3M). Kairos Pharma, Ltd. has the higher net margin (0.00% vs −523.0%) and the lower return on invested capital (−322.9% vs 0.00%). Across the 14 metrics below, Kairos Pharma, Ltd. leads on 8 and PMGC Holdings Inc. on 6.

Valuation

Metric ELAB KAPA Biotechnology median
P/E n/m n/m 8.50
P/S 0.52 n/m 9.71
P/B 0.08 0.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.53 0.14 0.64
EV/Sales (6.66) n/m 9.21
Earnings yield (38,441.73%) (326.58%) (33.15%)
Free cash flow yield (665.71%) (216.16%) (25.50%)

Profitability

Metric ELAB KAPA Biotechnology median
Gross margin 31.08% — 65.16%
Operating margin (458.63%) 0.00% 0.00%
Net margin (522.99%) 0.00% 0.00%
Free cash flow margin (348.69%) 0.00% 0.00%
Return on equity (104.60%) (113.96%) (56.36%)
Return on assets (58.71%) (104.32%) (48.04%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric ELAB KAPA Biotechnology median
Revenue growth (TTM) 5.41% — 6.02%
EPS growth (last fiscal year) 94.22% (30.44%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ELAB KAPA Biotechnology median
Debt to equity 0.02 0.00 0.00
Current ratio 1.36 11.98 4.72
Net debt to EBITDA 0.87 1.65 0.96

Dividend

Metric ELAB KAPA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ELAB KAPA Biotechnology median
Market cap 2.46m 2.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack